A patient in a small mRNA vaccine trial shows no evidence of pancreatic cancer that was previously considered terminal, marking a significant early result.
A major clinical trial shows a personalised mRNA vaccine combined with immunotherapy cuts the risk of death or melanoma recurrence by 42% in patients with advanced skin cancer.
